<code id='3707186FA2'></code><style id='3707186FA2'></style>
      • <acronym id='3707186FA2'></acronym>
      <center id='3707186FA2'><center id='3707186FA2'><tfoot id='3707186FA2'></tfoot></center><abbr id='3707186FA2'><dir id='3707186FA2'><tfoot id='3707186FA2'></tfoot><noframes id='3707186FA2'>
      • <optgroup id='3707186FA2'><strike id='3707186FA2'><sup id='3707186FA2'></sup></strike><code id='3707186FA2'></code></optgroup>
        5. <b id='3707186FA2'><label id='3707186FA2'><select id='3707186FA2'><dt id='3707186FA2'><span id='3707186FA2'></span></dt></select></label></b><u id='3707186FA2'></u>
          <i id='3707186FA2'><strike id='3707186FA2'><tt id='3707186FA2'><pre id='3707186FA2'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / leisure time      
           
     
           
      
          leisure time 
           
      
           
      
           
       2025-08-24 19:09:25 
   
      
           
      
           
                        
          leisure time  
          
                                   
                 
                                      author：hotspot   
                                        
                                      
                                      Page View：2
                                  
                                    
          
                                   
          Adam's take main illustration
          Molly Ferguson/STAT
          Biotech is awash in PIPEs.
          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.
          advertisement
          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.
          Get unlimited access to award-winning journalism and exclusive events.					
          Subscribe																						Log In															
                      
                              
          
                                 Previous article：

                                
                                          The a glaring gap in research on serious mental illness and primary care
                                
                            
          Next article：  
                                      
                                          After affirmative action ruling, medical educators look to 'holistic review'
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles